Showing results (1851-1860 of 2,938) with videos related to
Sort By:
Pageof 294
Cancer Investigation|October 10, 2003
Vinorelbine and cisplatin for metastatic breast cancer: a salvage regimen in patients progressing after docetaxel and anthracycline treatmentM Vassilomanolakis, G Koumakis, M Demiri, et al.Cancer Investigation|October 10, 2003
Phase II trial of 96-hour paclitaxel in previously treated patients with advanced esophageal cancerSibyl E Anderson, Eileen M O'Reilly, David P Kelsen, et al.Cancer Investigation|October 10, 2003
Detection of recurrent or residual nasopharyngeal carcinomas after radiotherapy with technetium-99m tetrofosmin single photon emission computed tomography and comparison with computed tomography--a preliminary studyChih-Jaan Tai, Yu-Chien Shiau, Jhi-Joung Wang, et al.Cancer Investigation|October 10, 2003
Leukemia in severe congenital neutropenia: defective proteolysis suggests new pathways to malignancy and opportunities for therapyMarshall Horwitz, Feng-Qian Li, Dalila Albani, et al.Cancer Investigation|October 10, 2003
UFT and oral leucovorin as radiation sensitizers in rectal and other gastrointestinal malignanciesEverardo D Saad, Paulo M HoffCancer Investigation|October 10, 2003
Novel perspective: focusing on the X chromosome in reproductive cancersDezhong Joshua Liao, Qian-qian Du, Bennett W Yu, et al.Cancer Investigation|January 12, 2005
Low overexpression of HER-2/neu in advanced colorectal cancer limits the usefulness of trastuzumab (Herceptin) and irinotecan as therapy. A phase II trialRamesh K Ramanathan, Jimmy J Hwang, William C Zamboni, et al.Cancer Investigation|September 18, 2008
RAS: target for cancer therapyNandita Saxena, Sitanshu Sekhar Lahiri, Shashank Hambarde, et al.Cancer Investigation|September 18, 2008
Resistin in human colorectal cancer: increased expression independently of resistin promoter -420C > G genotypeDick Wågsater, Melad Mumtaz, Sture Lofgren, et al.Pageof 294